ReviewJournal of translational medicine2025
Emerging versatile nanozymes for the therapeutic and diagnostic applications of diseases.
Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology.Micromachines · 2026Review
- Metal-Functionalized Nanozymes in Antibacterial Wound Management: Recent Advances and Future Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nanozyme has become a new rising star in the medical field because of its high stability, strong catalysis, ease of modification and manufacturing compared with natural enzyme. Nanozyme can regulate reactive oxygen species (ROS), such as down-regulation in inflammation and up-regulation in tumor. Nanozyme plays an important role in treatment of various diseases due to this ability. Additionally, nanozyme can corporate with traditional and novel therapies, which are of tremendous help in both therapeutic and diagnostic aspects. In this review, we summarize the classification and mechanism of action of nanozyme, and its therapeutic and diagnostic applications in various diseases, especially focusing on its potential application for inflammation related diseases, cancer, neurological disorders, cardiovascular diseseases, metabolic diseases, infectious diseases, artificial implants and biomedical detection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.